News + Filings Transactions
|
Gallagher Brian M. Jr.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/20/2023 | eFFECTOR Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 50.9k | $0.47 | $23.9k | | 01/20/2023 |
| 06/23/2022 | eFFECTOR Therapeutics, Inc. | | Purchase | Common Stock | 30k | $1.59 | $47.7k | | 06/23/2022 |
| 06/09/2022 | eFFECTOR Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 20k | $1.65 | $33k | | 06/09/2022 |
| 10/06/2021 | eFFECTOR Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 40k | $11.36 | $454.4k | | 10/06/2021 |
| 10/06/2021 | eFFECTOR Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 40k | $11.36 | $454.4k | | 10/06/2021 |
| 08/25/2021 | eFFECTOR Therapeutics, Inc. | | Grant | Earn-out Right | 605.3k | $0.00 | $0 | By Abingworth Bioventures VI, LP | 08/25/2021 |
| 08/25/2021 | eFFECTOR Therapeutics, Inc. | | Grant | Common Stock | 4.8M | $0.00 | $0 | By Abingworth Bioventures VI, LP | 08/25/2021 |
| 07/02/2018 | Translate Bio, Inc. | TBIO | Conversion | Series C Preferred Stock | 2.5M | $0.00 | $0 | See Footnote | 07/02/2018 |
| 07/02/2018 | Translate Bio, Inc. | TBIO | Conversion | Series B Preferred Stock | 7.2M | $0.00 | $0 | See Footnote | 07/02/2018 |
| 07/02/2018 | Translate Bio, Inc. | TBIO | Conversion | Series A Preferred Stock | 9.3M | $0.00 | $0 | See Footnote | 07/02/2018 |
| 07/02/2018 | Translate Bio, Inc. | TBIO | Purchase | Common Stock | 269.2k | $13.00 | $3.5M | See Footnote | 07/02/2018 |
| 07/02/2018 | Translate Bio, Inc. | TBIO | Conversion | Common Stock | 454.6k | $0.00 | $0 | See Footnote | 07/02/2018 |
| 07/02/2018 | Translate Bio, Inc. | TBIO | Conversion | Common Stock | 1.3M | $0.00 | $0 | See Footnote | 07/02/2018 |
| 07/02/2018 | Translate Bio, Inc. | TBIO | Conversion | Common Stock | 1.7M | $0.00 | $0 | See Footnote | 07/02/2018 |
| 07/05/2017 | AILERON THERAPEUTICS INC | ALRN | Conversion | Series F Preferred Stock | 2M | $0.00 | $0 | See Footnote | 07/05/2017 |
| 07/05/2017 | AILERON THERAPEUTICS INC | ALRN | Conversion | Series E-3 Preferred Stock | 1.3M | $0.00 | $0 | See Footnote | 07/05/2017 |
| 07/05/2017 | AILERON THERAPEUTICS INC | ALRN | Conversion | Series E-2 Preferred Stock | 1.5M | $0.00 | $0 | See Footnote | 07/05/2017 |
| 07/05/2017 | AILERON THERAPEUTICS INC | ALRN | Conversion | Series D Preferred Stock | 6.8M | $0.00 | $0 | See Footnote | 07/05/2017 |
| 07/05/2017 | AILERON THERAPEUTICS INC | ALRN | Purchase | Common Stock | 273.3k | $15.00 | $4.1M | See Footnote | 07/05/2017 |
| 07/05/2017 | AILERON THERAPEUTICS INC | ALRN | Conversion | Common Stock | 1.2M | $0.00 | $0 | See Footnote | 07/05/2017 |
|